Skip to content

Clinical trials

Completed Non-alcoholic Fatty Liver Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Status: Completed Country / region: United States Clear all

345 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20034
20043
20059
20069
20077
200812
20096
20108
20114
20128
201310
201412
201526
201621
201717
201829
201941
202026
202138
202220
202319
202410
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed345

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)17
Gilead Sciences11
Massachusetts General Hospital11
Pfizer11
University of California, San Diego8
Corcept Therapeutics7
Washington University School of Medicine7
AstraZeneca6
Bristol-Myers Squibb6
University of Michigan6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease345
Fatty Liver74
Obesity48
Liver Diseases38
Diabetes Mellitus, Type 223
Fibrosis23
Insulin Resistance22
Liver Cirrhosis19
Diabetes Mellitus17
Metabolic Syndrome13

Trials

Showing 1 to 25 of 345. Each trial links to its page on Pharma Observatory.

245 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.